HEALTHCARE CONNEXIONS
DEAD

Serial Number

86028689

Owner

TELERx Marketing, Inc.

Attorney

HOPE V. SHOVEIN

First Use Date

Oct 1, 2013

Filing Date

Aug 5, 2013

Add to watchlist:

No watchlists yet
View on USPTO

HEALTHCARE CONNEXIONS Trademark

Serial Number: 86028689 • Registration: 4941746

HEALTHCARE CONNEXIONS is a trademark filed by TELERx Marketing, Inc. on August 5, 2013. The trademark is classified under Class 36 (Insurance & Financial), Class 42 (Computer & Scientific), Class 44 (Medical Services), Class 45 (Legal & Security Services), Class 35 (Advertising & Business). The application is currently no longer active.

Owner Contact Info

TELERx Marketing, Inc. (38 trademarks)

Springhouse, PA 19477

Entity Type: 03

Trademark Details

Filing Date

August 5, 2013

Registration Date

April 19, 2016

First Use Anywhere

October 1, 2013

First Use in Commerce

October 1, 2013

Published for Opposition

July 29, 2014

Cancellation Date

November 4, 2022

Goods & Services

Business process outsourcing services for others in the fields of pharmacy and healthcare, namely, pharmaceutical benefit management services, including verification of benefit eligibility and patient enrollment

Customer service management and customer relationship management services for others in the fields of pharmacy and healthcare, healthcare and pharmacy access and reimbursement programs, and healthcare and consumer packaged goods; business process outsourcing services for others in the fields of pharmacy and healthcare, healthcare and pharmacy access and reimbursement (A and R) programs, and healthcare and consumer packaged goods (CPG), namely, providing consumers with information about products and services of others in response to consumer interactions such as inquiries and complaints, and using such inquiries to: increase product/service sales via inbound up-selling and cross-selling of products and services, increase repeat purchases and lifetime value, and improve and increase brand loyalty; order fulfillment services; administration of patient reimbursement programs with regard to medication and treatment; marketing analysis services to provide trends and to gain insight into consumer behavior; business and marketing services for others provided via an interactive voice response system, namely, processing telephone inquiries regarding products and services of others, responding to customer inquiries regarding products and services of others, and telephone order-taking services; administration of patient support and adherence programs featuring appointment scheduling services, physician referrals, and customer follow-ups for customer service and business purposes; marketing analysis and marketing services, namely, monitoring and administration of branded social media advertising for others

Business process outsourcing services for others in the fields of pharmacy and healthcare, namely, providing information, advice, and consulting in the field of drug safety and pharmacovigilance as it relates to drug safety; providing drug safety services and pharmacovigilance services related to drug safety, namely, collecting, analyzing, and processing data related to adverse events and product quality complaints, aggregate reporting of adverse events and product quality complaints, and product life cycle case handling related to adverse events and product quality complaints

Business process outsourcing services for others in the fields of pharmacy and healthcare, namely, providing and administering disease management programs including remote assistance, advice, and support; patient support and adherence services, namely, providing doctor's appointment and prescription refill reminder services and following up with patients to determine whether they are adhering to medical advice and taking prescribed medications

Technical support services, namely, troubleshooting of computer software problems; pharmacovigilance services for others, namely, scientific research and analysis pertaining to adverse events and product quality complaints regarding pharmaceutical products, assessment of risks presented by certain pharmaceutical products or combinations thereof, and product safety testing and consultation related thereto in the field of pharmaceuticals

Filing History

CANCELLED SEC. 8 (6-YR)
Nov 4, 2022 C8..
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Apr 19, 2021 REM1
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Aug 5, 2020 CHAN
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Aug 5, 2020 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Aug 5, 2020 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Aug 5, 2020 REAP
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Aug 5, 2020 COAR
REGISTERED-PRINCIPAL REGISTER
Apr 19, 2016 R.PR
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Mar 17, 2016 SUNA
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Mar 16, 2016 CNPR
STATEMENT OF USE PROCESSING COMPLETE
Mar 16, 2016 SUPC
ASSIGNED TO EXAMINER
Mar 15, 2016 DOCK
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Jan 28, 2016 CHAN
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Jan 28, 2016 COAR
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Sep 29, 2015 EXRA
SOU EXTENSION 2 GRANTED
Sep 28, 2015 EX2G
CASE ASSIGNED TO INTENT TO USE PARALEGAL
Sep 28, 2015 AITU
USE AMENDMENT FILED
Sep 21, 2015 IUAF
SOU EXTENSION 2 FILED
Sep 21, 2015 EXT2
SOU TEAS EXTENSION RECEIVED
Sep 21, 2015 EEXT
TEAS STATEMENT OF USE RECEIVED
Sep 21, 2015 EISU
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Mar 21, 2015 EXRA
SOU EXTENSION 1 GRANTED
Mar 19, 2015 EX1G
SOU EXTENSION 1 FILED
Mar 19, 2015 EXT1
SOU TEAS EXTENSION RECEIVED
Mar 19, 2015 EEXT
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Sep 23, 2014 NOAM
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Aug 5, 2014 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Aug 5, 2014 REAP
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jul 29, 2014 NPUB
PUBLISHED FOR OPPOSITION
Jul 29, 2014 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jul 9, 2014 NONP
LAW OFFICE PUBLICATION REVIEW COMPLETED
Jun 26, 2014 PREV
ASSIGNED TO LIE
Jun 26, 2014 ALIE
APPROVED FOR PUB - PRINCIPAL REGISTER
Jun 10, 2014 CNSA
EXAMINER'S AMENDMENT ENTERED
Jun 10, 2014 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Jun 10, 2014 GNEN
EXAMINERS AMENDMENT E-MAILED
Jun 10, 2014 GNEA
EXAMINERS AMENDMENT -WRITTEN
Jun 10, 2014 CNEA
TEAS/EMAIL CORRESPONDENCE ENTERED
May 20, 2014 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
May 19, 2014 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
May 19, 2014 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Nov 20, 2013 GNRN
NON-FINAL ACTION E-MAILED
Nov 20, 2013 GNRT
NON-FINAL ACTION WRITTEN
Nov 20, 2013 CNRT
ASSIGNED TO EXAMINER
Nov 13, 2013 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Aug 12, 2013 NWOS
NEW APPLICATION ENTERED
Aug 8, 2013 NWAP